The Economist
Jeff Haxer sat down with The Economist’s Schumpeter columnist to discuss the current state of healthcare M&A and what sets pharma apart from other industries.
Jeff Haxer sat down with The Economist’s Schumpeter columnist to discuss the current state of healthcare M&A and what sets pharma apart from other industries.